Drugs by condition
Drugs approved for acromegaly
Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
10
Still marketed, NDA or BLA
Drug classes
2
Novel drugs
5
New molecular entities and new biologics
In development
4
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for acromegaly.
- Palsonify (Paltusotine Hydrochloride) · Crinetics NovelOrphanSep 25, 2025
- Bynfezia Pen (Octreotide Acetate) · Sun Pharm Sep 27, 2024
- Mycapssa (Octreotide Acetate) · Chiesi OrphanJun 26, 2020
- Signifor Lar Kit (Pasireotide Pamoate) · Recordati Rare OrphanDec 15, 2014
- Somatuline Depot (Lanreotide Acetate) · Ipsen Pharma NovelOrphanAug 30, 2007
All approved drugs for acromegaly, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 19 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Somatostatin Analog (1)
- Mycapssa Octreotide Acetate · Chiesi · 2020
Class not listed in FDA's data (9)
- Palsonify Paltusotine Hydrochloride · Crinetics · 2025
- Somatuline Depot Lanreotide Acetate · Ipsen Pharma · 2007
- Somavert Pegvisomant · Pharmacia · 2003
- Sandostatin Octreotide Acetate · Novartis · 1988
- Parlodel Bromocriptine Mesylate · Esjay Pharma · 1978
- Bynfezia Pen Octreotide Acetate · Sun Pharm · 2024
- Signifor Lar Kit Pasireotide Pamoate · Recordati Rare · 2014
- Sandostatin Lar Octreotide Acetate · Novartis · 1998
- R-Gene 10 Arginine Hydrochloride · Pharmacia and Upjohn · 1973
Drugs in development for acromegaly
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- CAM2029octreotide depotPhase 33 trials
Camurus AB · Polycystic Liver Disease, Gastro-enteropancreatic Neuroendocrine Tumor, Acromegaly
- SYHX2008Phase 33 trials
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Diagnosed With Acromegaly, Currently in the Active Stage of the Disease, Gastrointestinal Neuroendocrine Pancreatic Tumor, Acromegaly
- Debio 4126Phase 31 trial
Debiopharm International SA · Acromegaly
- MAR002Phase 21 trial
Marea Therapeutics · Acromegaly
1 discontinued brand-name drugs whose label still names it
- Lanreotide Acetate Lanreotide Acetate
More on acromegaly: recruiting trials · published research
Related in endocrinology and women's health: Hypothyroidism · Osteoporosis · Menopause symptoms · Endometriosis · Uterine fibroids · Birth control · Low testosterone · Growth hormone deficiency · Cushing's syndrome
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.